Evidence map›Paper›PMID 25787310›Full record

ArticleScientific reports2015

Phytonutrient diet supplementation promotes beneficial Clostridia species and intestinal mucus secretion resulting in protection against enteric infection.

Marta Wlodarska, Benjamin P Willing, David M Bravo, B Brett Finlay

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Effects ofAnimals : an open access journal from MDPI · 2022
    Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Marta Wlodarska1] Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4 [2] Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, V6T 1Z4.
Benjamin P WillingDepartment of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton AB, T6G 2P5.
David M BravoPancosma, Geneva, Switzerland.
B Brett Finlay1] Michael Smith Laboratories, University of British Columbia, Vancouver, BC, V6T 1Z4 [2] Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, V6T 1Z4 [3] Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, V6T 1Z4.
Canada's Michael Smith Genome Sciences Centre · CAUniversity of Alberta · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant extracts, or phytonutrients, are used in traditional medicine practices as supplements to enhance the immune system and gain resistance to various infectious diseases and are used in animal production as health promoting feed additives. To date, there are no studies that have assessed their mechanism of action and ability to alter mucosal immune responses in the intestine. We characterized the immunomodulatory function of six phytonutrients: anethol, carvacrol, cinnamaldehyde, eugenol, capsicum oleoresin and garlic extract. Mice were treated with each phytonutrient to assess changes to colonic gene expression and mucus production. All six phytonutrients showed variable changes in expression of innate immune genes in the colon. However only eugenol stimulated production of the inner mucus layer, a key mucosal barrier to microbes. The mechanism by which eugenol causes mucus layer thickening likely involves microbial stimulation as analysis of the intestinal microbiota composition showed eugenol treatment led to an increase in abundance of specific families within the Clostridiales order. Further, eugenol treatment confers colonization resistance to the enteric pathogen Citrobacter rodentium. These results suggest that eugenol acts to strengthen the mucosal barrier by increasing the thickness of the inner mucus layer, which protects against invading pathogens and disease.

Indexed as

AnimalsCitrobacter rodentiumColonDietary SupplementsEnterobacteriaceae InfectionsEubacterialesEugenolImmunity, MucosalIntestinal MucosaMaleMedicine, TraditionalMiceMicrobiotaPeptostreptococcusPhytochemicalsRNA, Ribosomal, 16SEugenolPhytochemicalsRNA, Ribosomal, 16S

Identifiers

PMID25787310
PMCPMC4365398
OpenAlexW1989040902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.